Transaction · 0001998491-26-000002

Schmid Timothy

Schmid Timothy, EVP, CHAIR, reported a transaction classified as exercise at JOHNSON & JOHNSON involving 15571.000000 shares for an estimated $1586217.77. Reported holdings after the transaction were 32460.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

exerciseSEC transaction code MEVP, CHAIR
JNJJOHNSON & JOHNSON
Filing timeFeb 11
Trade dateFeb 06, 2026
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
$240.86
Pre-filing
1mo ago -13.9%1w ago -5.7%1d ago -1.3%
Returns since
7d +1.7%30d +0.3%90d -6.9%180d +8.7%1y +13.4%

JNJ price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
JNJ since 2026-02-11Filed 205 days ago · 30 days of pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
exercise
Code M
Identifier
0001998491-26-000002
Common Stock
Transaction date
Feb 06, 2026
Filed Feb 11, 2026, 02:46 AM · 5d delay
Shares
15.5k sh
$10.1k per share
Estimated value
$158M
Computed from shares × price
Holdings after
32.4k sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
Direct Ownership Large Holdings Increase
+6score
Filing-only score

+6

Compact filing score computed from stored Form 4 facts. Version v1.

Positive filing signal

This filing has a modest positive filing-only score. Treat it as a useful flag for review, not as a buy signal.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

EVP, WW Chair, MedTech

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    Reflects the auto-exercise of options immediately prior to their expiration.

  2. F2

    Shares withheld for payment of the exercise price and taxes in connection with the exercise of the options reported on this Form 4.

  3. F3

    Includes shares accrued due to dividend reinvestment in the Johnson & Johnson Stock Fund under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (1/31/2026).

  4. F4

    Shares held by ESOP under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (1/31/2026).

Original filing · 0001998491-26-000002
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

JNJ